Clinical Trials Directory

Trials / Completed

CompletedNCT02828371

Early Stepping Verticalization in ICU for ABI Patients

Effectiveness of a Very Early Stepping Verticalization Protocol in Severe Acquired Brain Injured Patients: a Randomized Pilot Study in ICU

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Ospedale Generale Di Zona Moriggia-Pelascini · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Verticalization was reported to improve the level of arousal and awareness in patients with severe acquired brain injury (ABI) and to be safe in ICU. The investigators evaluated the effectiveness of a very early stepping verticalization protocol on the functional and neurological outcome of patients affected by disorder of consciousness due to ABI. Consecutive patients with Vegetative State or Minimally Conscious State were enrolled in ICU on the third day after an ABI. They were randomized to undergo conventional physiotherapy alone or associated to fifteen 30-minute sessions of verticalization, using a tilt table with robotic stepping device. Once stabilized, patients were transferred to a Neurorehabilitation unit for an individualized treatment. Outcome measures were assessed on the third day from the injury (T0), at ICU discharge (T1) and at Rehab discharge (T2).

Conditions

Interventions

TypeNameDescription
DEVICEstepping verticalizationAfter patient positioning, the slope of the tilt table was gradually increased from 0° to 20°, 40° and then 60° in a time span of nine minutes. The stepping frequency was set at 20 steps/min for the entire treatment. Cardiovascular and respiratory parameters were continuously monitored. The net time of the session was 30 minutes
OTHERconventional mobilizationin-bed physiotherapy (mobilization exercises in supine and sitting position on bed, without out-of-bed mobilization nor verticalization)

Timeline

Start date
2015-01-01
Primary completion
2015-11-01
Completion
2015-12-01
First posted
2016-07-11
Last updated
2016-07-11

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02828371. Inclusion in this directory is not an endorsement.